We use some essential cookies to make this website work. These cookies are used to improve your website experience. To find out more about the cookies we use, see our Privacy Policy.
We’d also like to use analytics cookies so we can understand how you use the service and make improvements.
Use these toggles to accept or reject individual cookies. To find out more about the cookies we use, see our Privacy Policy.
Partnerships
Trusted by pharma, biotech, diagnostics, academia and healthcare providers
Cut development timelines, increase probability of success and extend patent life of your assets with mechanistic drug-biology simulations
Adopt next-generation digital twin technology for trial design optimisation, synthetic controls and enriched responder groups even in niche indications and early phases
Simulate comprehensive therapy scenarios by transforming fragmented patient data into biologically-rooted digital twins
Turn your data into knowledge by adopting our Bayesian biological foundation layer to fill the data gaps and enable high-accuracy response simulations
If you’d like more information or have an enquiry, please contact us.
